Results 241 to 250 of about 524,934 (294)
Acute intrapartum deep venous thrombosis: A case report
International Journal of Gynecology &Obstetrics, EarlyView.
Faith Arimoro +2 more
wiley +1 more source
Safety and efficacy of continuous intra-arterial infusion of heparin administration in mechanical thrombectomy for acute ischemic stroke: a single-center retrospective study. [PDF]
Meng T +7 more
europepmc +1 more source
Probing Glycosaminoglycan-Protein Interactions: Applications of Surface Plasmon Resonance. [PDF]
Bu C +6 more
europepmc +1 more source
Safety and Efficacy of Adjunctive Heparin Infusion During Catheter-Directed Thrombolysis for Acute Limb Ischemia. [PDF]
Mehanna A +3 more
europepmc +1 more source
Antithrombotic Polymers: A Narrative Review on Current and Future Strategies for Their Design, Synthesis, and Application. [PDF]
Smola-Dmochowska A +5 more
europepmc +1 more source
VLX-1005, but not argatroban, prevents ITAM-mediated platelet activation and heparin-induced thrombocytopenia. [PDF]
Yamaguchi A +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
JAMA: The Journal of the American Medical Association, 1974
To the Editor.— The difference in potency of heparin from various tissues is the reason that dosages must be expressed in units of activity rather than in milligrams. Since by United States Pharmacopoeia standards 1 mg of heparin sodium from lung tissue is not less than 120 USP units, while 1 mg of heparin sodium from intestinal mucosa is not less ...
openaire +1 more source
To the Editor.— The difference in potency of heparin from various tissues is the reason that dosages must be expressed in units of activity rather than in milligrams. Since by United States Pharmacopoeia standards 1 mg of heparin sodium from lung tissue is not less than 120 USP units, while 1 mg of heparin sodium from intestinal mucosa is not less ...
openaire +1 more source
Current Opinion in Hematology, 2002
Fondaparinux (a synthetic heparin analogue) (Sanofi-Synthelabo; Paris, France and Organon Research; Oss, The Netherlands) is the subject of intense recent clinical evaluation for the prevention and treatment of venous and arterial thromboembolism. The drug replicates the sulphated antithrombin-binding pentasaccharide sequence in heparin and induces ...
Alexander S, Gallus, Douglas W, Coghlan
openaire +2 more sources
Fondaparinux (a synthetic heparin analogue) (Sanofi-Synthelabo; Paris, France and Organon Research; Oss, The Netherlands) is the subject of intense recent clinical evaluation for the prevention and treatment of venous and arterial thromboembolism. The drug replicates the sulphated antithrombin-binding pentasaccharide sequence in heparin and induces ...
Alexander S, Gallus, Douglas W, Coghlan
openaire +2 more sources

